Acutus Medical, Inc.

AFIB Healthcare Medical Devices

In the quarter to December 2024, revenue grew 204.2%, EPS grew 95.9% and free cash flow grew 76.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

0.00 0.00 NaN
Market cap
$1.7M
P/E
0.0×
Fwd P/E
−0.5×
Dividend yield
—
F-score
3/9
Altman Z
−28.52
Beneish M
−2.49
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24
Cash and Short Term Investments
17.90 71.95 131.22 100.92 76.21 29.43 14.02
Receivables
0.16 0.26 2.16 3.63 17.92 11.35 7.88
Inventory
3.00 8.42 12.96 16.41 1.79 4.28 1.79
Other current assets
0.88 1.82 4.65 4.43 4.70 — —
Total current assets
21.94 82.46 151.39 126.29 117.87 46.25 25.58
Property, Plant, Equpment (Net)
3.92 4.43 12.36 13.67 1.67 0.83 0.52
Long-Term Investments
— — 8.73 7.12 — — —
Goodwill and Intangible Assets (Total)
— 16.14 17.68 17.04 — — —
Long-term assets (Other)
0.09 0.10 0.72 1.15 0.09 0.09 0.09
Total non-current assets
4.01 23.00 41.15 43.50 15.57 7.71 3.07
Total Assets
25.95 105.46 192.54 169.79 133.44 53.96 28.65
Accounts Payable
1.60 3.88 8.27 7.52 2.47 2.76 1.28
Accrued Expenses
5.15 10.08 7.31 9.10 3.31 2.89 3.01
Current Part of Debt
11.27 0.83 0.93 0.40 0.32 1.86 7.01
Other current liabilities
6.84 17.12 5.40 1.50 5.15 0.41 0.19
Total current liabilities
24.86 31.91 21.91 18.51 19.87 18.94 12.44
Long Term Debt (Total)
14.59 38.24 39.01 40.42 34.43 32.65 25.56
Non-current Liabilities (Other)
0.00 5.70 3.90 0.55 0.01 — —
Total non-current liabilities
14.59 46.00 44.05 45.56 38.55 35.90 27.80
Total liabilities
39.45 77.91 65.95 64.07 58.42 54.84 40.24
Additional Paid In Capital
30.15 33.25 487.29 584.61 594.17 599.94 598.67
Preferred Stock (Total)
118.32 253.36 — — — — —
Common Stock (Net)
0.00 0.00 0.03 0.03 0.03 0.03 0.03
Retained Earnings
(161.99) (259.03) (361.01) (478.70) (518.31) (599.98) (609.52)
Common Equity (Total)
(131.82) (225.81) 126.58 105.73 75.02 (0.88) (11.59)
Shareholders Equity (Total)
(13.50) 27.55 126.58 105.73 75.02 (0.88) (11.59)
Shareholders Equity and Liabilities (Total)
25.95 105.46 192.54 169.79 133.44 53.96 28.65
Shares (Common)
0.66 0.70 27.99 27.96 28.56 29.31 29.91
Shares (Preferred)
7.98 16.18 0.00 0.01 0.01 0.01 0.01
Shareholders Equity (Tangible)
(13.50) 11.41 108.90 88.69 75.02 (0.88) (11.59)
Net Debt
7.97 (32.88) (91.28) (60.11) (41.46) 5.09 18.55
Total Debt
25.87 39.08 39.94 40.81 34.75 34.52 32.57

Fold the line items

In millions of $ except per-share values · columns are period end dates